-
Product Insights
Anal Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Anal Cancer - Drugs In Development, 2023’, provides an overview of the Anal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isunakinra in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isunakinra in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isunakinra in Prostate Cancer Drug Details: Isunakinra (EBI-005) was under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isunakinra in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isunakinra in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isunakinra in Colorectal Cancer Drug Details: Isunakinra (EBI-005) was under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isunakinra in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isunakinra in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isunakinra in Pancreatic Cancer Drug Details: Isunakinra (EBI-005) was under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isunakinra in Anal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isunakinra in Anal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isunakinra in Anal Cancer Drug Details: Isunakinra (EBI-005) was under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Isunakinra in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isunakinra in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isunakinra in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Isunakinra...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isunakinra in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isunakinra in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isunakinra in Triple-Negative Breast Cancer (TNBC) Drug Details: Isunakinra...
-
Product Insights
Buzzard Field, United Kingdom
Buzzard Field is a producing field located in North Sea, United Kingdom. It is being operated by CNOOC Petroleum Europe Ltd. Empower your strategies with our Buzzard Field, United Kingdom report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
-
Sector Analysis
United Kingdom (UK) Oil and Gas Exploration and Production Market Volumes and Forecast by Terrain, Assets and Major Companies, 2023 Update
The United Kingdom (UK) Oil and Gas Exploration and Production Market Report Overview The United Kingdom’s oil and gas production mainly stems from offshore terrain, major examples include the North Sea, Irish Sea, and West of Shetlands. The oil and gas industry in the UK plays a very important role in the economy, accounting for over three-quarters of the UK’s primary energy. Oil and gas being major sources of fuel for the transportation, electricity, heating generation and petrochemical industries. The...